Cargando…
An innovative phase I study in healthy subjects to determine the mass balance, elimination, metabolism, and absolute bioavailability of mitapivat
Mitapivat, a first‐in‐class, oral, small‐molecule, allosteric activator of the red blood cell‐specific form of pyruvate kinase (PKR), was approved for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency. In this phase I mass balance study in healthy males, we administere...
Autores principales: | Prakash, Chandra, Mangus, Heidi, Yan, Yan, Yang, Hua, Iyer, Varsha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582659/ https://www.ncbi.nlm.nih.gov/pubmed/37596712 http://dx.doi.org/10.1111/cts.13609 |
Ejemplares similares
-
Investigation of the absolute bioavailability and human mass balance of navoximod, a novel IDO1 inhibitor
por: Ma, Shuguang, et al.
Publicado: (2019) -
Absolute bioavailability and regional absorption of ticagrelor in healthy volunteers
por: Teng, Renli, et al.
Publicado: (2014) -
A Phase 1, Open-Label Study in Healthy Subjects to Evaluate the Absolute Bioavailability of AG-221 by a Microtracer Approach
por: Wang, Xiaomin, et al.
Publicado: (2019) -
Intraindividual Variability in Absolute Bioavailability and Clearance of Midazolam in Healthy Individuals
por: Kvitne, Kine Eide, et al.
Publicado: (2023) -
A Phase 1 Study to Assess Mass Balance and Absolute Bioavailability of Zimlovisertib in Healthy Male Participants Using a (14)C‐Microtracer Approach
por: Singh, Ravi Shankar P., et al.
Publicado: (2022)